Amir London, CEO of Kamada Pharmaceuticals, was recently a guest on Benzinga's All-Access. Kamada is a global biopharmaceutical company with a portfolio of assets indicated for rare and serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results